Nebula Research & Development LLC Day One Biopharmaceuticals, Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 19,804 shares of DAWN stock, worth $162,986. This represents 0.03% of its overall portfolio holdings.
Number of Shares
19,804
Previous 10,107
95.94%
Holding current value
$162,986
Previous $141 Million
78.22%
% of portfolio
0.03%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding DAWN
# of Institutions
175Shares Held
77.1MCall Options Held
139KPut Options Held
253K-
Atlas Venture Life Science Advisors, LLC6.43MShares$52.9 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$48.1 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$47.4 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$40.1 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$37.3 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $605M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...